129777286963281250_35ER Kang pharmaceutical drug-assisted industry consolidation will more or less be mergers and acquisitions accelerated
"Er Kang pharmaceutical (300,267) net profit last year rose more than 70%, has entered the fast-growing channel. "On March 30, er Kang, Chairman of pharmaceutical shuaifang said at the 2011 annual general meeting of shareholders. Data show that in 2011, er Kang pharmacy specializing in revenue of $ 608 million, an increase of 67.18%; net profit of 119 million dollars,Rose 77.14%; medicinal materials of which operating income to $ 415 million, main business 68.26%. In January of this year, the Ministry announced the pharmaceutical industry "Twelve-Five" plans, and medicinal materials into five key areas of development for the first time and the State Council recently announced the national medicines safety "Twelve-Five" in the planning of further made clear will be close to 132 pharmaceutical excipient standards, planning 200 medicinal materials standard as pharmaceutical industry "Twelve-Five" key planning tasks and projects. "The pharmaceutical sector improve overall product quality standard will promote the development of medicinal materials industry. "Handsome think this launch reflects the national dimensions of policy on this growing attention, drug-assisted development of leading enterprises to gain moreSpace and market opportunities. It is understood that as at December 31, 2011, er Kang pharmaceutical has 117 medicinal materials registered a superior, first in the country, more than dier��San��siming in the industry, and
tera gold, there are 35 products belonging to special products and exclusive offers while 67 accessories new products was declared superior. On the general meeting of shareholders, investors ask
tera gold, medicinal materialsUnder the influence of distance, a certain radius sales
tera power leveling, companies have no merger plans? "The company had numerous contacts with the intent object is still in the stage of discussions and observation. "Shuai said. Guotai Junan researcher Yi Jingming said, er Kang pharmaceutical policy at present is the Happy Valley enclosure, seize, and layout of the perfect marketing network, deep markets, forecast 2012-year growth is expected to remain in 40%. Gross profit margin, er Kang, Chairman of pharmaceutical shuaifang said: "drug-assisted rate fell slightly last year, but not last, the future is more likely to pick up. In 2011, under the influence of inflation and rising labor costs, directly leading to drug-assisted by rising production costs, in view of this situation, the company can according to customer demand and marketTo adjust product prices. "Handsome description, medicinal materials represent a low cost of finished drugs companies, usually less than 5%; result finished drugs companies is not sensitive to prices of medicinal materials, generally pay more attention to suppliers of the convenience brought about by the quality assurance system and product range.
Others:
没有评论:
发表评论